Are women with MS at an increased risk of cervical dysplasia and/or cancer?

Research Opportunity
Masters by Research, Honours, Master of Biomedical Science
Project Status
Future
Department
Medicine and Radiology
Location
Royal Melbourne Hospital
Supervisor Email Number Webpage
Dr Anneke van der Walt anneke.vanderwalt@mh.org.au
Dr Vilija Jokubaitis

Project Details

Disease modifying treatments in MS are used in the majority of patients with relapsing forms of multiple sclerosis. Many of the available treatments are relatively new and the longterm side-effects of these drugs are not known. The risk of cervical dysplasia and cervical cancer due to HPV is increased in immuno-deficient women through a variety of mechanisms.

This study aims to collect MS disease specific factors, exposure to disease modifying treatments and risk factors for cervical dysplasia (smoking, vaccination status, sexual partners). Data will be matched with pap smear results stored at the Victorian Cervical Cytology Registry. The project is suited to a motivated student interested in a clinical project.



Faculty Research Themes

Cancer, Neuroscience

School Research Themes

Cancer in Medicine, Neuroscience & Psychiatry



Research Opportunities

Masters by Research, Honours, Master of Biomedical Science Graduate Research Students who are interested in joining this project will need to consider their elegibility as well as other Graduate Research requirements before contacting the supervisor of this research

Read more

Key Contact

For further information about this research, please contact a supervisor.

Department

Medicine and Radiology

Research Group / Unit / Centre

MS and Comorbidities Team

Research Node

Royal Melbourne Hospital